Ligand validation:4AD5

DMJ: 1-DEOXYMANNOJIRIMYCIN

DMJ is a Ligand Of Interest in 4AD5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AD5_DMJ_A_501	16%	39%	0.222	0.788	0.65	1.72	-	1	2	0	100%	1
4AD3_DMJ_A_501	93%	49%	0.079	0.975	0.73	1.21	-	1	0	0	100%	1
5MEH_DMJ_A_506	100%	14%	0.034	0.995	2.56	1.31	4	2	0	0	100%	0.5
4D4C_DMJ_B_500	95%	49%	0.057	0.961	0.76	1.21	-	1	0	0	100%	1
3QRY_DMJ_A_430	87%	38%	0.079	0.949	1.18	1.23	2	2	0	0	100%	1
1FO2_DMJ_A_704	78%	1%	0.084	0.925	3.51	3.98	6	5	1	0	100%	1
6ZJ5_DMJ_AAA_508	65%	35%	0.156	0.96	0.87	1.67	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.